Skip to main content
logo
Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China flag China · Delayed Price · Currency is CNY
5.09
-0.18 (-3.42%)
Aug 24, 2026, 3:04 PM CST

SHE:300006 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
-128.46-134.71-87.8-8.93-68.71-100.53
Depreciation & Amortization
49.5251.9255.872.7776.4174.76
Other Amortization
2.21.951.262.651.781.42
Loss (Gain) From Sale of Assets
-0.02-0.03-0.49-0.45-0.250.03
Asset Writedown & Restructuring Costs
61.0762.3525.750.710.090.51
Loss (Gain) From Sale of Investments
24.1821.1418.88-85.74-5.78-47.92
Provision & Write-off of Bad Debts
4.284.282.06-1.69-5.59-1.42
Other Operating Activities
9.687.256.98-14.5944.5466.98
Change in Accounts Receivable
-17.4449.27239.8751.39142.18-54.29
Change in Inventory
0.2539.580.9927.64-46.6663.34
Change in Accounts Payable
68.47-53.33-75.35-50.76-20.24118.1
Change in Other Net Operating Assets
---0.382.59-51.46-
Operating Cash Flow
50.5926.04185.0381.5357.13108.28
Operating Cash Flow Growth
-17.71%-85.93%126.94%42.70%-47.24%-51.78%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-35.07-41.75-78.62-59.32-68.18-38.66
Sale of Property, Plant & Equipment
0.380.310.040.1600.74
Cash Acquisitions
---11.01---
Divestitures
0.780.78--12.29-78.12
Investment in Securities
-24.11-19.364.22-60.2980.2114.3
Other Investing Activities
10.368.557.074.641.812.69
Investing Cash Flow
-47.65-51.4-18.31-127.1113.82157.19

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Issued
-294.95391.6294.9352.5171
Short-Term Debt Repaid
------180.91
Long-Term Debt Repaid
--430.79-181.23-362.86-206.88-1,084
Total Debt Repaid
-448.34-430.79-181.23-362.86-206.88-1,265
Net Debt Issued (Repaid)
71.86-135.84210.37-67.96145.62-1,094
Issuance of Common Stock
-----1,065
Common Dividends Paid
-10.88-12.35-10.76-11.8-17.47-29.08
Other Financing Activities
34.5130.22-9.67-1.4837.9194.2
Financing Cash Flow
95.5-117.96189.94-81.24166.0736.05

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-2.11-0.960.440.572.77-0.86
Net Cash Flow
96.33-144.29357.1-126.25239.79300.67

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
15.52-15.71106.4122.21-11.0569.63
Free Cash Flow Growth
171.96%-379.04%---61.32%
Free Cash Flow Margin
2.07%-2.02%13.37%2.48%-1.25%5.68%
Free Cash Flow Per Share
0.01-0.010.100.02-0.010.07
Levered Free Cash Flow
73.7319.0168.2617.68211.44-66.92
Unlevered Free Cash Flow
82.3327.6275.2125.48224.16-46.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
76.5477.39126.87132.63114.96166.12
Change in Working Capital
28.1411.88162.6116.7914.64114.46